Laboratory biomarkers for multiple sclerosis and their role in clinical practice
Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS) most commonly diagnosed in young adults. In recent decades, new treatments have emerged that have radically changed the prognosis and quality of life of these patients. However, this has also raised new challenges in p...
Saved in:
| Main Authors: | I. Navickaitë, G. Žemgulytė, R. Balnytė |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Vilnius University Press
2023-11-01
|
| Series: | Neurologijos seminarai |
| Subjects: | |
| Online Access: | https://www.journals.vu.lt/neurologijos_seminarai/article/view/33564 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Concordance rate between oligoclonal bands and the Kappa index in patients with suspected multiple sclerosis (MS)
by: Renan Barros Domingues, et al.
Published: (2024-03-01) -
DIAGNOSTIC AND PROGNOSTIC SIGNIFICANCE OF INTRATHECAL SYNTHESIS OF IMMUNOGLOBULIN FREE LIGHT CHAINS IN MULTIPLE SCLEROSIS
by: V. D. Nazarov, et al.
Published: (2015-06-01) -
Oligoclonal band on the 5-year prognosis of patients with multiple sclerosis
by: Masoud Ghiasian, et al.
Published: (2025-03-01) -
The Kappa Free Light Chains Index and Central Vein Sign: Two New Biomarkers for Multiple Sclerosis Diagnosis
by: Michael Levraut, et al.
Published: (2025-04-01) -
Multiple sclerosis in Brazil: analysis of cerebrospinal fluid by standard methods
by: MARZIA PUCCIONI-SOHLER, et al.
Published: (1999-12-01)